Cutaneous manipulation of vascular growth factors leads to alterations in immunocytes, blood vessels and nerves: Evidence for a cutaneous neurovascular unit

Journal of Dermatological Science

Volumn 61, Issue 1, 2011, Pages 14-22

  Ward, Nicole L ^a,b,c   Hatala, Denise A ^a   Wolfram, Julie A ^a   Knutsen, Dorothy A ^a   Loyd, Candace M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Angiogenesis; Nerve; Neurovascular; Plasticity; Transgenic mice

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; VASCULOTROPIN;

ACANTHOSIS; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DERMOEPIDERMAL JUNCTION; ENDOTHELIUM CELL; EPIDERMIS; GENE OVEREXPRESSION; IMMUNOCOMPETENT CELL; KERATINOCYTE; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN NERVE;

ANGIOPOIETIN-1; ANIMALS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; EPITHELIAL CELLS; KERATINOCYTES; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; SKIN; SKIN PHYSIOLOGICAL PHENOMENA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78650679600     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.11.004     Document Type: Article

References (98)

1. Brouard M., Barrandon Y. Controlling skin morphogenesis: hope and despair. Curr Opin Biotechnol 2003, 14(5):520-525.
2. Park J.A., Choi K.S., Kim S.Y., Kim K.W. Coordinated interaction of the vascular and nervous systems: from molecule- to cell-based approaches. Biochem Biophys Res Commun 2003, 311(2):247-253.
3. Ward N., LaManna J.C. The neurovascular unit and its growth factors: coordinated response in the vascular and nervous systems. Neurol Res 2004, 26:879-883.
4. Zacchigna S., de Almodovar C.R., Carmeliet P. Similarities between angiogenesis and neural development: what small animal models can tell us. Curr Top Dev Biol 2008, 80:1-55.
5. Ward N.L., Dumont D.J. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 2002, 13(1):19-27.
6. Dumont D.J., Gradwohl G., Fong G.H., Puri M.C., Gertsenstein M., Auerbach A., et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994, 8(16):1897-1909.
7. Nourhaghighi N., Teichert-Kuliszewska K., Davis J., Stewart D.J., Nag S. Altered expression of angiopoietins during blood-brain barrier breakdown and angiogenesis. Lab Invest 2003, 83(8):1211-1222.
8. Lemieux C., Maliba R., Favier J., Theoret J.-F., Merhi Y., Sirois M.G. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2005, 105(4):1523-1530.
9. Brkovic A., Pelletier M., Girard D., Sirois M.G. Angiopoietin chemotactic activities on neutrophils are regulated by PI-3K activation. J Leukoc Biol 2007, 81(4):1093-1101.
10. Gamble J.R., Drew J., Trezise L., Underwood A., Parsons M., Kasminkas L., et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 2000, 87(7):603-607.
11. Kim I., Oh J.L., Ryu Y.S., So J.N., Sessa W.C., Walsh K., et al. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells. FASEB J: Off Publ Feder Am Soc Exp Biol 2002, 16(1):126-128.
12. Kim I., Moon S.O., Park S.K., Chae S.W., Koh G.Y. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 2001, 89(6):477-479.
13. Larcher F., Franco M., Bolontrade M., Rodriguez-Puebla M., Casanova L., Navarro M., et al. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis. Mol Carcinog 2003, 37(2):83-90.
14. Kosacka J., Figiel M., Engele J., Hilbig H., Majewski M., Spanel-Borowski K. Angiopoietin-1 promotes neurite outgrowth from dorsal root ganglion cells positive for Tie-2 receptor. Cell Tissue Res 2005, 320(1):11-19.
15. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286(5449):2511-2514.
16. Suri C., McClain J., Thurston G., McDonald D.M., Zhou H., Oldmixon E.H., et al. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998, 282(5388):468-471.
17. Wolfram J.A., Diaconu D., Hatala D.A., Rastegar J., Knutsen D.A., Lowther A., et al. Keratinocyte but not endothelial cell specific overexpression of Tie2 leads to the development of psoriasis. Am J Pathol 2009, 174:1443-1458.
18. Frank S., Hubner G., Breier G., Longaker M.T., Greenhalgh D.G., Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995, 270(21):12607-12613.
19. Mukouyama Y.S., Shin D., Britsch S., Taniguchi M., Anderson D.J. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 2002, 109(6):693-705.
20. Wakui S., Yokoo K., Muto T., Suzuki Y., Takahashi H., Furusato M., et al. Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest 2006, 86(11):1172-1184.
21. Dumont D.J., Fong G.H., Puri M.C., Gradwohl G., Alitalo K., Breitman M.L. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 1995, 203(1):80-92.
22. Mor F., Quintana F.J., Cohen I.R. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 2004, 172(7):4618-4623.
23. Stockmann C., Kerdiles Y., Nomaksteinsky M., Weidemann A., Takeda N., Doedens A., et al. Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis. Proc Natl Acad Sci USA 2010, 107(9):4329-4334.
24. Kasama T., Miwa Y., Isozaki T., Odai T., Adachi M., Kunkel S.L. Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 2005, 4(3):273-279.
25. Senger D.R., Perruzzi C.A., Feder J., Dvorak H.F. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986, 46(11):5629-5632.
26. Detmar M., Brown L.F., Schon M.P., Elicker B.M., Velasco P., Richard L., et al. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998, 111(1):1-6.
27. Larcher F., Murillas R., Bolontrade M., Conti C.J., Jorcano J.L. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 1998, 17(3):303-311.
28. Kunstfeld R., Hirakawa S., Hong Y.K., Schacht V., Lange-Asschenfeldt B., Velasco P., et al. Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 2004, 104(4):1048-1057.
29. Xia Y.P., Li B., Hylton D., Detmar M., Yancopoulos G.D., Rudge J.S. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 2003, 102(1):161-168.
30. Wilgus T.A., Matthies A.M., Radek K.A., Dovi J.V., Burns A.L., Shankar R., et al. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol 2005, 167(5):1257-1266.
31. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 1999, 19(14):5731-5740.
32. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001, 28(2):131-138.
33. Ogunshola O.O., Antic A., Donoghue M.J., Fan S.Y., Kim H., Stewart W.B., et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 2002, 277(13):11410-11415.
34. Silverman W.F., Krum J.M., Mani N., Rosenstein J.M. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 1999, 90(4):1529-1541.
35. Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 2000, 97(18):10242-10247.
36. Jin K., Zhu Y., Sun Y., Mao X.O., Xie L., Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 2002, 99(18):11946-11950.
37. Matsuzaki H., Tamatani M., Yamaguchi A., Namikawa K., Kiyama H., Vitek M.P., et al. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J 2001, 15(7):1218-1220.
38. Thurston G., Rudge J.S., Ioffe E., Zhou H., Ross L., Croll S.D., et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000, 6(4):460-463.
39. Sarao R., Dumont D.J. Conditional transgene expression in endothelial cells. Transgenic Res 1998, 7(6):421-427.
40. Kistner A., Gossen M., Zimmermann F., Jerecic J., Ullmer C., Lèubbert H., et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996, 93(20):10933-10938.
41. Diamond I., Owolabi T., Marco M., Lam C., Glick A. Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol 2000, 115(5):788-794.
42. Akeson A.L., Greenberg J.M., Cameron J.E., Thompson F.Y., Brooks S.K., Wiginton D., et al. Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung. Dev Biol 2003, 264(2):443-455.
43. Jones N., Voskas D., Master Z., Sarao R., Jones J., Dumont D.J. Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2001, 2(5):438-445.
44. Ward N.L., Haninec A.L., Van Slyke P., Sled J.G., Sturk C., Henkelman R.M., et al. Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease. Am J Pathol 2004, 165(3):889-899.
45. Sheehan D.C.H.B.B. Theory and practice of histotechnology 1980, Battelle Press, Detroit. 2nd ed.
46. Kosacka J., Nowicki M., Kacza J., Borlak J., Engele J., Spanel-Borowski K. Adipocyte-derived angiopoietin-1 supports neurite outgrowth and synaptogenesis of sensory neurons. J Neurosci Res 2006, 83(7):1160-1169.
47. Ward N.L., Putoczki T., Mearow K., Ivanco T.L., Dumont D.J. Vascular-specific growth factor angiopoietin 1 is involved in the organization of neuronal processes. J Comp Neurol 2004, 482(3):244-256.
48. Chen X., Fu W., Tung C.E., Ward N.L. Angiopoietin-1 induces neurite outgrowth of PC12 cells in a Tie2-independent, beta1-integrin-dependent manner. Neurosci Res 2009, 64(4):348-354.
49. Bai Y., Cui M., Meng Z., Shen L., He Q., Zhang X., et al. Ectopic expression of angiopoietin-1 promotes neuronal differentiation in neural progenitor cells through the Akt pathway. Biochem Biophys Res Commun 2009, 378(2):296-301.
50. Sondell M., Sundler F., Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 2000, 12(12):4243-4254.
51. Marko S.B., Damon D.H. VEGF promotes vascular sympathetic innervation. Am J Physiol Heart Circ Physiol 2008, 294(6):H2646-H2652.
52. Ismail N.S., Pravda E.A., Li D., Shih S.-C., Dallabrida S.M. Angiopoietin-1 reduces H2O2-induced increases in reactive oxygen species and oxidative damage to skin cells. J Invest Dermatol 2010.
53. Huang I.T., Lin W.M., Shun C.T., Hsieh S.T. Influence of cutaneous nerves on keratinocyte proliferation and epidermal thickness in mice. Neuroscience 1999, 94(3):965-973.
54. Yu X.J., Li C.Y., Xu Y.H., Chen L.M., Zhou C.L. Calcitonin gene-related peptide increases proliferation of human HaCaT keratinocytes by activation of MAP kinases. Cell Biol Int 2009.
55. Nickoloff B.J., Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999, 155(1):145-158.
56. Conrad C., Boyman O., Tonel G., Tun-Kyi A., Laggner U., de Fougerolles A., et al. Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med 2007, 13(7):836-842.
57. Venneri M.A., Palma M.D., Ponzoni M., Pucci F., Scielzo C., Zonari E., et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 2007, 109(12):5276-5285.
58. Scott J.R., Tamura R.N., Muangman P., Isik F.F., Xie C., Gibran N.S. Topical substance P increases inflammatory cell density in genetically diabetic murine wounds. Wound Repair Regen 2008, 16(4):529-533.
59. Ding W., Stohl L.L., Wagner J.A., Granstein R.D. Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J Immunol 2008, 181(9):6020-6026.
60. Torii H., Yan Z., Hosoi J., Granstein R.D. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves. J Invest Dermatol 1997, 109(4):586-591.
61. Inoshima N., Nakanishi Y., Minami T., Izumi M., Takayama K., Yoshino I., et al. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Clin Cancer Res 2002, 8(11):3480-3486.
62. Huang Y., Chen X., Dikov M.M., Novitskiy S.V., Mosse C.A., Yang L., et al. Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF. Blood 2007, 110(2):624-631.
63. Mimura K., Kono K., Takahashi A., Kawaguchi Y., Fujii H. Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2. Cancer Immunol Immunother 2007, 56(6):761-770.
64. Ohm J.E., Shurin M.R., Esche C., Lotze M.T., Carbone D.P., Gabrilovich D.I. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo. J Immunol 1999, 163(6):3260-3268.
65. Oyama T., Ran S., Ishida T., Nadaf S., Kerr L., Carbone D.P., et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 1998, 160(3):1224-1232.
66. Reinders M.E., Sho M., Izawa A., Wang P., Mukhopadhyay D., Koss K.E., et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 2003, 112(11):1655-1665.
67. Lee T.-H., Avraham H., Lee S.-H., Avraham S. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J. Biol. Chem. 2002, 277(12):10445-10451.
68. Hattori K., Dias S., Heissig B., Hackett N.R., Lyden D., Tateno M., et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 2001, 193(9):1005-1014.
69. Carmeliet P., Storkebaum E. Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin Cell Dev Biol 2002, 13(1):39-53.
70. Ferretti A., Boschi E., Stefani A., Spiga S., Romanelli M., Lemmi M., et al. Angiogenesis and nerve regeneration in a model of human skin equivalent transplant. Life Sci 2003, 73(15):1985-1994.
71. Gu X.H., Terenghi G., Kangesu T., Navsaria H.A., Springall D.R., Leigh I.M., et al. Regeneration pattern of blood vessels and nerves in cultured keratinocyte grafts assessed by confocal laser scanning microscopy. Br J Dermatol 1995, 132(3):376-383.
72. Kangesu T., Manek S., Terenghi G., Gu X.H., Navsaria H.A., Polak J.M., et al. Nerve and blood vessel growth in response to grafted dermis and cultured keratinocytes. Plast Reconstr Surg 1998, 101(4):1029-1038.
73. Mukouyama Y.S., Gerber H.P., Ferrara N., Gu C., Anderson D.J. Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 2005, 132(5):941-952.
74. Griffith L.G., Naughton G. Tissue engineering-current challenges and expanding opportunities. Science 2002, 295(5557):1009-1014.
75. Jiang W.-Y., Raychaudhuri S.P., Farber E.M. Double-labeled immunofluorescence study of cutaneous nerves in psoriasis. Int J Dermatol 1998, 37(8):572-574.
76. Naukkarinen A., Nickoloff B.J., Farber E.M. Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 1989, 92(1):126-129.
77. Farber E.M., Lanigan S.W., Boer J. The role of cutaneous sensory nerves in the maintenance of psoriasis. Int J Dermatol 1990, 29(6):418-420.
78. Kuroda K., Sapadin A., Shoji T., Fleischmajer R., Lebwohl M. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol 2001, 116(5):713-720.
79. Creamer D., Sullivan D., Bicknell R., Barker J. Angiogenesis in psoriasis. Angiogenesis 2002, 5(4):231-236.
80. Creamer J.D., Barker J.N. Vascular proliferation and angiogenic factors in psoriasis. Clin Exp Dermatol 1995, 20(1):6-9.
81. Baker B.S., Fry L. The immunology of psoriasis. Br J Dermatol 1992, 126(1):1-9.
82. Mordovtsev V.N., Albanova V.I. Morphology of skin microvasculature in psoriasis. Am J Dermatopathol 1989, 11(1):33-42.
83. Raychaudhuri S.P., Raychaudhuri S.K. Role of NGF and neurogenic inflammation in the pathogenesis of psoriasis. Prog Brain Res 2004, 146:433-437.
84. Hern S., Stanton A.W., Mellor R., Levick J.R., Mortimer P.S. Control of cutaneous blood vessels in psoriatic plaques. J Invest Dermatol 1999, 113(1):127-132.
85. Menke N.B., Ward K.R., Witten T.M., Bonchev D.G., Diegelmann R.F. Impaired wound healing. Clin Dermatol 2007, 25(1):19-25.
86. Fukai T., Takeda A., Uchinuma E. Wound healing in denervated rat skin. Wound Repair Regen 2005, 13(2):175-180.
87. Kampfer H., Pfeilschifter J., Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 2001, 81(3):361-373.
88. Galeano M., Altavilla D., Cucinotta D., Russo G.T., Calo M., Bitto A., et al. Recombinant human erythropoietin stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetes 2004, 53(9):2509-2517.
89. Galiano R.D., Tepper O.M., Pelo C.R., Bhatt K.A., Callaghan M., Bastidas N., et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004, 164(6):1935-1947.
90. Martin A., Komada M.R., Sane D.C. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003, 23(2):117-145.
91. Loomans C.J.M., de Koning E.J.P., Staal F.J.T., Rookmaaker M.B., Verseyden C., de Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53(1):195-199.
92. Echtermeyer F., Streit M., Wilcox-Adelman S., Saoncella S., Denhez F., Detmar M., et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J Clin Invest 2001, 107(2):R9-14.
93. Chang C.J., Yu J.S., Nelson J.S. Confocal microscopy study of neurovascular distribution in facial port wine stains (capillary malformation). J Formos Med Assoc 2008, 107(7):559-566.
94. Lachgar S., Charveron M., Gall Y., Bonafe J.L. Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes. Dermatology 1999, 199(Suppl. 1):25-27.
95. Lonne-Rahm S., Nordlind K., Edstrom D.W., Ros A.M., Berg M. Laser treatment of rosacea: a pathoetiological study. Arch Dermatol 2004, 140(11):1345-1349.
96. Draelos Z.D. Noxious sensory perceptions in patients with mild to moderate rosacea treated with azelaic acid 15% gel. Cutis 2004, 74(4):257-260.
97. Draelos Z.D. Assessment of skin barrier function in rosacea patients with a novel 1% metronidazole gel. J Drugs Dermatol 2005, 4(5):557-562.
98. Sowinska-Glugiewicz I., Ratajczak-Stefanska V., Maleszka R. Role of psychological factors in course of the rosacea. Rocz Akad Med Bialymst 2005, 50(Suppl. 1):49-53.